SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-101340
Filing Date
2020-04-08
Accepted
2020-04-08 16:09:56
Documents
2
Group Members
ALAN FRAZIERFHM VI, L.L.C.FHM VI, L.P.JAMES TOPPERNADER NAININATHAN EVERYPATRICK HERON

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G d915247dsc13ga.htm SC 13G/A 154198
2 EX-99.A d915247dex99a.htm EX-99.A 14045
  Complete submission text file 0001193125-20-101340.txt   169954
Mailing Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101
Business Address 601 UNION STREET, SUITE 3200 SEATTLE WA 98101 206-621-7200
Frazier Healthcare VI, L.P. (Filed by) CIK: 0001456656 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Subject) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87213 | Film No.: 20782097
SIC: 2834 Pharmaceutical Preparations